🎙 Listen to @jerskillington, CEO of @PoolbegPharma and Tushar Pandey, CEO and Co-founder of @SimBioSys, as they discuss the growing role of #AI in drug development on the latest episode of #OptimumPerspectives!
Stream the full episode here: Optimum Perspectives Podcast – Optimum Strategic Communications (https://t.co/cXtB8J343C) and don't forget to subscribe on your favourite podcast platform so you never miss the latest updates from the #LifeScience community brought to you by #OptimumStrategicCommunications!
We are thrilled to announce our first FDA 510(k) clearance for our digital precision medicine technology, TumorSight™! This milestone allows us to deliver on our vision to redefine precision medicine and revolutionize patient care.
Read more here: https://t.co/Rwb4RepSL7
We are excited to announce a strategic collaboration with the @MayoClinic for the development of novel digital medicine solutions for patients to help improve quality of life, starting with #breastcancer.
Read more about this exciting collaboration here: https://t.co/wdJEK9PudT
It’s not too late to register for @DDWJournal's Cancer Summit! Join our CTO and Co-founder, Dr. Joseph Peterson, alongside other leaders in the field to discuss the latest advancements in cancer drug discovery research.
Register here: https://t.co/ZxU6ptbYvi
Interested in learning more about the latest advancements and tools in cancer drug discovery? Our CTO and Co-founder Dr. Joseph Peterson will be speaking alongside other leaders in the field during @DDWJournal's Cancer Summit!
Register: https://t.co/ZxU6ptbYvi
DDW Turning Science Into Business Summit: Cancer research opportunities and advances
Thu, Nov 16, 2023 3:00 PM - 5:00 PM GMT
To secure your place, register for FREE now.
https://t.co/orbUSKB834
Sponsored by @Taconic#Oncology
As our product pipeline continues to advance, now is the perfect time to update our website to reflect all of our important progress! Learn more about the exciting things happening, including the latest on our TumorSight and PhenoScope platforms: https://t.co/oa9IBjxrVQ
As #BreastCancerAwarenessMonth ends, we reflect on how we can better serve patients so that they may live longer & better.
Dr. Barry Rosen shares how recent tech, including our TumorSight platform, can help ensure that patients receive the best care.
https://t.co/eb1ojaIdb9
🎗️Today, on #MetastaticBreastCancerAwarenessDay, we raise awareness for the thousands of individuals battling this chronic disease. SimBioSys is dedicated to helping to individualize care and improve outcomes.
Learn more to #LightUpMBC: https://t.co/v6NuJiUCaK
If you’re attending the conference, please be sure to attend our presentation with Joseph Peterson on Friday and stop by Booth #1 to learn more about how PhenoScope™ Discovery can help uniquely advance your cancer research capabilities.
Join us at the Spatial Biology for Drug Development Summit to explore how this rapidly changing technology is becoming a crucial component of successful drug development programs and how we can help. Learn more: https://t.co/JavbCY5vo3
October is #BreastCancerAwarenessMonth. We've made much progress in treating this disease, but we can still do better. We’re developing our TumorSight technology to help doctors create treatment plans that are personalized for each patient – learn more: https://t.co/IzNRi3cF0u
@SimBioSys CEO Tushar Pandey was interviewed in a recent episode of the CRPN Central Podcast. It's always great to hear from EnterpriseWorks tenants: listen to this podcast today at https://t.co/TOq71OfhFD.
Check out this recent @JournalofCP article by Matthew Biancalana and Tushar Pandey. They discuss how #AI can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses: https://t.co/OW2mzFpIrb
This week CancerX announced its strategic priorities for 2023-2024 and its inaugural steering committee aligning their priorities with the broader Cancer Moonshot community.
Learn about CancerX strategic priorities here: https://t.co/p3iCeKXq8J
We are thrilled to be part of the Chicago biotech community supporting the CancerX initiative and partnering with @_DiMeSociety and @MoffittNews in the fight against #cancer. Read more about our involvement with the initiative as a founding member. https://t.co/gYazHOE15y
If you are attending the #AGBT#PrecisionHealth meeting today, don’t miss out on the opportunity to connect with Dr. Daniel Cook during his poster presentation from 4:35 p.m. to 6:35 p.m. Learn more about our next-generation technology for #surgicalplanning.
We’re excited to showcase our #surgicalplanning platform at the @agbt#PrecisionHealth, an annual meeting that keeps bringing innovative technologies to light.
Our Director of Bioinformatics & Metabolism, Dr. Daniel Cook, will present our technology tomorrow @ 4:35 p.m.-6:35 p.m.